Welch & Forbes LLC boosted its holdings in shares of Xylem Inc. (NYSE:XYL – Free Report) by 3.4% during the second quarter, Holdings Channel reports. The institutional investor owned 381,335 shares of the industrial products company’s stock after acquiring an additional 12,513 shares during the quarter. Welch & Forbes LLC’s holdings in Xylem were worth $49,329,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in Xylem by 1.3% during the first quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company’s stock worth $3,465,122,000 after buying an additional 362,127 shares in the last quarter. Swedbank AB lifted its position in shares of Xylem by 13.9% during the 2nd quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company’s stock worth $564,906,000 after buying an additional 531,890 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Xylem by 7.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,024,500 shares of the industrial products company’s stock worth $480,767,000 after buying an additional 274,123 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of Xylem by 689.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock worth $443,074,000 after buying an additional 3,239,203 shares during the period. Finally, Northern Trust Corp lifted its position in shares of Xylem by 2.9% during the 1st quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company’s stock worth $401,743,000 after buying an additional 94,560 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.
Xylem Stock Down 0.3%
NYSE XYL opened at $151.00 on Friday. The stock has a fifty day moving average of $144.74 and a 200-day moving average of $134.38. The stock has a market capitalization of $36.76 billion, a P/E ratio of 38.82, a price-to-earnings-growth ratio of 2.50 and a beta of 1.13. Xylem Inc. has a 52 week low of $100.47 and a 52 week high of $154.27. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.96.
Xylem Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th were paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend was Thursday, August 28th. Xylem’s dividend payout ratio (DPR) is 41.13%.
Insider Buying and Selling at Xylem
In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction on Friday, September 5th. The stock was sold at an average price of $139.96, for a total transaction of $139,960.00. Following the completion of the sale, the chief accounting officer directly owned 2,957 shares of the company’s stock, valued at $413,861.72. The trade was a 25.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Claudia S. Toussaint sold 10,421 shares of Xylem stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total value of $1,590,661.44. Following the sale, the executive vice president directly owned 31,250 shares of the company’s stock, valued at approximately $4,770,000. This trade represents a 25.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.27% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Several research firms recently commented on XYL. Mizuho set a $160.00 target price on Xylem in a research report on Wednesday. Barclays upped their price objective on shares of Xylem from $165.00 to $172.00 and gave the stock an “overweight” rating in a research note on Wednesday. Zacks Research raised shares of Xylem from a “hold” rating to a “strong-buy” rating in a research note on Monday, September 22nd. Royal Bank Of Canada lifted their price objective on Xylem from $169.00 to $176.00 and gave the company an “outperform” rating in a research report on Wednesday. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Xylem in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, Xylem currently has an average rating of “Moderate Buy” and a consensus target price of $166.20.
View Our Latest Research Report on XYL
About Xylem
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Stories
- Five stocks we like better than Xylem
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Is Beyond Meat a Buy After Meme Stock Surge? Analysts Say No
- Insider Selling Explained: Can it Inform Your Investing Choices?
- ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Super Micro’s Moment of Truth: A Growth Story Under Pressure
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
